While IL-6 is a central mediator of hyperinflammatory responses and a well-established marker in syndromes such as sepsis, CRS, and HLH [7,17,18], growing evidence indicates that its prognostic capacity is enhanced when analyzed within a multi-cytokine context rather than in isolation [42]. This evidence concerns the gene IL6 and congenital rubella syndrome.